Obalon Announces Second Quarter 2019 Financial Results

SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity,?today announced its financial results for the second quarter ended June 30, 2019.